USA, 05-Mar-2015 / CTI Clinical Trial and Consulting Services,

CTI Clinical Trial and Consulting Services (CTI) to present at the 5th Annual Advanced Therapies Summit, a gathering of clinical researchers and business leaders from across North America, Europe, and Asia. The meeting takes place March 12, 2015 in Paris, France. CTI’s Chief Executive Officer, Timothy J. Schroeder, will speak as part of a discussion around “Cell Therapy Commercialization”. CTI is a supporting member of the Alliance for Regenerative Medicine, which sponsors the meeting.

“CTI is proud to participate in this cutting edge conference, where we will highlight our extensive experience in cell and gene therapy,” according to Schroeder. “We are currently working with more than 100 pharmaceutical, biotechnology, and medical device companies across the world, and we have been involved in more than 70 drug and device approvals over our sixteen year history.”

Schroeder, CTI’s founder, has over 30 years of clinical, academic, and industry experience in leading multi-national Phase I through Phase IV drug development programs. He leads CTI’s growth strategy, which now encompasses offices in more than 20 countries across four continents. He consults with global pharmaceutical and biotechnology companies on strategic decisions surrounding clinical and commercial drug development issues, and he has served as a reviewer to numerous FDA Advisory Panels, including CDER and CBER.

This image is available in original resolution to logged-in users.


For further information
CTI Clinical Trial and Consulting Services
Allison Schroeder
Media Contact

10123 Alliance Road
Cincinnati, OH 45242

Phone: 513 598 9290
Email: click to reveal